ARDT Ardent Health Partners
- 18.300
- -0.800-4.19%
- 18.300
- 0.0000.00%
Ardent Health Partners News
RBC Capital Maintains Ardent Health Partners(ARDT.US) With Buy Rating, Maintains Target Price $23
Ardent Health Partners Price Target Maintained With a $24.00/Share by Stephens & Co.
Ardent Health Partners Analyst Ratings
Morgan Stanley Maintains Ardent Health Partners(ARDT.US) With Buy Rating, Maintains Target Price $27
Analysts' Opinions Are Mixed on These Healthcare Stocks: Ardent Health Partners, Inc. (ARDT), AdaptHealth (AHCO) and Ramsay Health Care (OtherRMSYF)
Truist Financial Maintains Ardent Health Partners(ARDT.US) With Buy Rating, Maintains Target Price $22
Truist Financial Maintains Ardent Health Partners(ARDT.US) With Buy Rating, Announces Target Price $22
Loop Capital Maintains Ardent Health Partners(ARDT.US) With Buy Rating, Raises Target Price to $21
Morgan Stanley Maintains Ardent Health Partners(ARDT.US) With Buy Rating, Maintains Target Price $27
A Quick Look at Today's Ratings for Ardent Health Partners(ARDT.US), With a Forecast Between $21 to $27
Buy Rating Affirmed: Ardent Health Partners' Impressive Performance and Growth Potential
Analysts Are Bullish on These Healthcare Stocks: Biote (BTMD), Ardent Health Partners, Inc. (ARDT)
Ardent Health Partners Price Target Maintained With a $24.00/Share by Stephens & Co.
Ardent Health Partners Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Ascendis Pharma (ASND), Encompass Health (EHC) and Ardent Health Partners, Inc. (ARDT)
Loop Capital Initiates Ardent Health Partners(ARDT.US) With Buy Rating, Announces Target Price $18
Truist Financial Maintains Ardent Health Partners(ARDT.US) With Buy Rating
Morgan Stanley Maintains Ardent Health Partners(ARDT.US) With Buy Rating, Maintains Target Price $27
RBC Initiates Ardent Health Partners at Outperform With $23 Price Target
Ardent Health Partners, Inc.: Buy Rating With Strong Revenue and EBITDA Growth Potential
Analysis
Price Target
No Data
No Data
